Hiroshi Keino Selected Research

Bevacizumab (Avastin)

1/2011	Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
3/2009	Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Keino Research Topics

Disease

17	Inflammation (Inflammations) 01/2021 - 02/2003
13	Uveitis 01/2020 - 09/2002
6	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 02/2022 - 02/2010
5	Retinal Perforations 03/2022 - 12/2008
4	Behcet Syndrome (Behcet's Syndrome) 02/2017 - 10/2006
3	Hypersensitivity (Allergy) 09/2009 - 02/2007
2	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2015
2	Optic Atrophy 01/2022 - 01/2015
2	Necrosis 01/2020 - 02/2007
2	Scleritis (Episcleritis) 03/2011 - 11/2008
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 08/2004 - 09/2002
1	Cataract (Cataracts) 10/2022
1	Sarcoidosis (Schaumann Disease) 10/2022
1	COVID-19 02/2022
1	Disease Progression 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Cushing Syndrome 02/2017
1	Iridocyclitis 02/2017
1	Glaucoma 01/2017
1	Optic Neuritis (Retrobulbar Neuritis) 08/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2015
1	Arteritis 01/2015
1	Hyperemia 01/2015
1	Neovascular Glaucoma 01/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Panuveitis 02/2010
1	Neoplasms (Cancer) 09/2009
1	Endophthalmitis (Ophthalmia) 11/2008
1	Arthritis (Polyarthritis) 09/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2003
1	Dermatitis 09/2002
1	Anterior Uveitis 09/2002
1	Acute Retinal Necrosis Syndrome 09/2002
1	Skin Diseases (Skin Disease) 09/2002
1	Zoster Sine Herpete 09/2002
1	Herpes Zoster 09/2002
1	Herpes Zoster Ophthalmicus 09/2002

Drug/Important Bio-Agent (IBA)

6	Retinaldehyde (Retinal)IBA 01/2022 - 12/2008
5	Infliximab (Remicade)FDA Link 02/2017 - 09/2011
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 11/2008
3	fosfestrol (Kyorin)FDA Link 10/2022 - 01/2017
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2022 - 11/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2008
3	Interferon-gamma (Interferon, gamma)IBA 03/2011 - 02/2007
3	Proteins (Proteins, Gene)FDA Link 02/2008 - 09/2002
2	MicroRNAs (MicroRNA)IBA 03/2022 - 03/2015
2	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2015
2	CytokinesIBA 01/2021 - 05/2009
2	Peptides (Polypeptides)IBA 01/2017 - 08/2004
2	tamibaroteneIBA 08/2015 - 03/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2015 - 06/2010
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2015 - 03/2011
2	Vitamin A (Retinol)FDA LinkGeneric 01/2012 - 06/2010
2	Bevacizumab (Avastin)FDA Link 01/2011 - 03/2009
2	apilimodIBA 11/2010 - 01/2008
2	ChemokinesIBA 03/2010 - 02/2003
2	AntigensIBA 09/2009 - 09/2002
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Ointments (Pastes)IBA 01/2021
1	dehydroxymethylepoxyquinomicinIBA 01/2020
1	EndotoxinsIBA 01/2020
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 11/2018
1	Interleukin-10 (Interleukin 10)IBA 03/2017
1	Ophthalmic Solutions (Eye Drops)IBA 02/2017
1	GlucocorticoidsIBA 02/2017
1	betamethasone sodium phosphate FDA LinkGeneric 02/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Interleukin-22 (IL-22)IBA 06/2013
1	RetinoidsIBA 03/2011
1	NF-kappa B (NF-kB)IBA 11/2010
1	KIR ReceptorsIBA 02/2010
1	Fas Ligand Protein (Fas Ligand)IBA 02/2008
1	Interleukin-12 (IL 12)IBA 01/2008
1	Interleukin-8 (Interleukin 8)IBA 01/2008
1	OvalbuminIBA 06/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2007
1	Transforming Growth Factor beta2IBA 10/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 09/2003
1	Chemotactic FactorsIBA 02/2003
1	Tuberculin (PPD)IBA 09/2002

Therapy/Procedure

7	Therapeutics 01/2019 - 09/2011
2	Injections 01/2019 - 11/2018
2	Oral Administration 11/2010 - 01/2008
2	Intravitreal Injections 03/2009 - 02/2007
1	Vitrectomy 10/2022
1	Corneal Transplantation (Keratoplasty) 01/2019
1	Remission Induction 02/2017
1	Cataract Extraction 01/2017
1	Slit Lamp 02/2007